KOSDAQMachinery277810

Rainbow Robotics

₩448,500▲ 2.16%2026-10-02 close

Market Cap

₩8.7T

Turnover

₩28.4B

Volume

60,000 shares

Shares out.

19.4M

PER

5215.9×

PBR

67.3×

EPS

₩88

Dividend Yield

0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩0 per share · Prices as of the 2026-10-02 close

Report overview

Revenue Doubles, Losses Widen: At the Threshold of Mass Production

Second-quarter 2026 revenue roughly doubled year on year while the operating loss widened, making the key question whether Samsung Electronics-related demand and mobile humanoid field trials convert into genuine mass-production sales.

1
Q2 2026 revenue of KRW 12.31bn was about double the KRW 6.22bn of a year earlier, but the operating loss of KRW 2.03bn kept the company in the red.
2
Annual revenue rose from KRW 13.62bn in 2022 to KRW 34.12bn in 2025, and the operating margin improved from -292.2% in 2023 to -7.3% in 2025 as losses narrowed.
3
First-half mobile humanoid revenue of KRW 8.65bn accounted for 40.48% of the total, making it the largest product line (Edaily, August 2026).
4
Samsung Electronics is the largest shareholder with 35.0%, and first-half sales to Samsung accounted for about 27% of total revenue, up from 18% a year earlier.
5
The debt-to-equity ratio was just 7.1% at end-2025, yet operating cash flow was negative KRW 9.29bn in 2025 as cash outflows expanded.
6
A prosecution probe into alleged use of undisclosed information around the Samsung subsidiary transition leaves governance-related uncertainty outstanding.

Business structure

Rainbow Robotics is a robot platform company founded in 2011 by researchers from the KAIST Hubo Lab, which developed Korea's first biped walking robot, Hubo. Its roots lie in the KAIST Hubo Lab team, and Samsung Electronics identified it as a leading Korean robotics specialist.

The product lineup consists of a mobile humanoid combining dual-arm work capability with wheel-based mobility, quadruped walking robots often called robot dogs, and collaborative robot arms, alongside specialty products such as precision pointing and astronomy mounts.

The mix has shifted quickly: first-half mobile humanoid revenue reached KRW 8.65bn, or 40.48% of total revenue, becoming the largest product line (Edaily, August 2026). The largest customer is the parent company.

According to the semi-annual report, Samsung Electronics purchased KRW 5.68bn worth of goods in the first half, three times the KRW 1.92bn of a year earlier, and that represented about 27% of total revenue, up nearly ten percentage points from 18% in the prior-year first half.

Samsung invested KRW 86.8bn in 2023 for a 14.7% stake, then exercised a call option to lift its holding to 35.0% and become the largest shareholder, with the company consolidated as a Samsung subsidiary.

The competitive landscape splits between finished robots and core components: observers describe Rainbow Robotics as centered on finished robots and the Samsung partnership, while Robotis is centered on actuators, and Doosan Robotics lifted its North American revenue share to roughly 53% in the first half through solution expansion there.

The company is not limited to finished units: it aims to build a full lineup that also develops and sells core parts such as dexterous hands and actuators, so the degree of in-house component capability shapes its cost structure.

In collaborative robots, it has widened industry certification references, including what it describes as the world's first NSF-certified collaborative robot, verified for food hygiene safety and suited to food and beverage applications.

Earnings trend

Quarterly revenue · Operating profit

₩6.2B-₩2.1B25Q2₩10.7B-₩700M25Q3₩13B₩1.7B25Q4₩9.1B-₩1.6B26Q1₩12.3B-₩2B26Q2

RevenueOperating profit

Annual revenue · Operating profit

₩13.6B₩1.3B2022₩15.3B-₩44.6B2023₩19.3B-₩3B2024₩34.1B-₩2.5B2025

RevenueOperating profit

Quarterly results · Last 5 quarters
Quarter	Revenue	Operating profit	Op. margin
2025Q2	₩6.2B	-₩2.1B	−33.1%
2025Q3	₩10.7B	-₩700M	−6.7%
2025Q4	₩13B	₩1.7B	13.1%
2026Q1	₩9.1B	-₩1.6B	−17.3%
2026Q2	₩12.3B	-₩2B	−16.5%

Annual results
Year	Revenue	Operating profit	Net income (parent)	Op. margin	ROE	Debt-to-equity
2022	₩13.6B	₩1.3B	₩5.8B	9.6%	9.4%	23.8%
2023	₩15.3B	-₩44.6B	-₩900M	−292.2%	−0.7%	1.5%
2024	₩19.3B	-₩3B	₩2.1B	−15.4%	1.6%	5.4%
2025	₩34.1B	-₩2.5B	₩1.4B	−7.3%	1.1%	7.1%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-08-23

Earnings analysis

The annual pattern shows top-line expansion and weak profitability at the same time. Revenue grew from KRW 13.62bn in 2022 to KRW 15.26bn in 2023, KRW 19.35bn in 2024 and KRW 34.12bn in 2025, more than doubling over three years.

Operating profit, by contrast, swung from a KRW 1.30bn profit in 2022 (9.6% margin) to a KRW 44.59bn loss in 2023 (-292.2%), then narrowed sharply to minus KRW 2.98bn (-15.4%) in 2024 and minus KRW 2.48bn (-7.3%) in 2025.

In 2023, against the KRW 44.59bn operating loss, the net loss attributable to owners was only KRW 0.89bn and operating cash flow only minus KRW 0.47bn, suggesting a large share of expense items that did not involve cash outflows.

In both 2024 and 2025, despite operating losses, net profit attributable to owners was positive at KRW 2.14bn and KRW 1.42bn respectively, indicating that non-operating items supported the bottom line. Quarterly results show clear seasonality.

Revenue rose from KRW 10.69bn in Q3 2025 (operating loss KRW 0.72bn) to KRW 13.02bn in Q4 with operating profit of KRW 1.70bn and net profit attributable to owners of KRW 2.71bn, consistent with the industry explanation that results improve on higher robot product sales and a concentration of fourth-quarter capital expenditure budget execution.

The company then returned to losses, with Q1 2026 revenue of KRW 9.06bn and an operating loss of KRW 1.57bn, and Q2 2026 revenue of KRW 12.31bn with an operating loss of KRW 2.03bn, while the Q2 net loss attributable to owners was limited to KRW 0.07bn.

Headcount build-out is cited as a driver of front-loaded costs: staff numbered 230 at the end of the second quarter, up 69 from the end of last year, with research focused on humanoid actuator technology (Asia Economy, August 2026).

The balance sheet is conservative, with the debt-to-equity ratio falling from 23.8% in 2022 to 7.1% in 2025, but operating cash flow outflows widened from minus KRW 0.47bn in 2023 to minus KRW 1.91bn in 2024 and minus KRW 9.29bn in 2025.

Industry analysis

The humanoid industry is transitioning from research and development toward mass production and supply-chain competition.

Shinhan Securities framed 2026 as the first year humanoids move beyond R&D into mass production and commercialization, estimating that Tesla would begin initial Optimus production around July or August 2026 (summary of a report published on 22 May 2026).

Korean conglomerates are pursuing distinct paths: Hyundai Motor Group unveiled a fully electric Atlas at CES 2026 and presented a roadmap for phased deployment at US plants from 2028, while LG Electronics is targeting a separate front in home humanoids.

On policy, the government aims through the K-Humanoid Alliance to invest more than KRW 1trn by 2030, developing a robot AI foundation model by 2028 and reaching annual output above 1,000 units by 2029, so part of demand carries a national-project character.

Still, while hardware capability is seen as near world-class, Korea is described as trailing the US and China in physical AI software, with converting field trials into actual revenue remaining the challenge. The legacy collaborative robot market is estimated to grow at a 18.9% compound annual rate globally (FnGuide).

Second-quarter 2026 results diverged across Korean robot makers: Robotis posted revenue of KRW 15.37bn, up 95.1%, and operating profit of KRW 1.98bn, up 722.9%, whereas Neuromeka saw revenue fall 17.9% to KRW 2.82bn with the operating loss widening to KRW 5.27bn.

Rainbow Robotics sits on the finished-robot and captive-customer axis, and one view holds that with Samsung Electronics as a captive buyer, Chinese rivals may lead on unit volumes while a different competitive structure could form around average selling prices and customer stability.

Outlook

On confirmed facts, the company's next step is converting trials into repeat orders. Management has said it can produce roughly 120 mobile humanoids a year as it prepares to expand the humanoid business.

Logistics adoption is under way: Coupang has deployed the RB-Y1 mobile dual-arm robot at a fulfillment center for validation, and large-scale orders are expected if the tests are passed (Electronic Times, June 2026), while supply to CJ logistics centers is reportedly under discussion, following an earlier joint development agreement with CJ Logistics for humanoids optimized for fulfillment centers.

On production, a brokerage noted that the relocation of the headquarters and production facilities was completed as of March (iM Securities, May 2026).

Parent-company reorganization is another variable: Samsung Electronics has consolidated its internal robot personnel and organizations under a Robotics Experience business unit reporting directly to CEO Roh Tae-moon, accelerating its robot initiative.

Research capacity is expanding quickly, as R&D headcount rose from 70 in the first half of last year to 114 this year, with master's-degree staff up from 29 to 52.

Partnerships are broadening: the company announced that in April 2026 it pursued joint development of a manufacturing-focused AI dual-arm robot V2 with Plaif, and in March signed an agreement with Heonin Town Development on adopting AI security robots, and in April 2026 Aidin Robotics signed the first official domestic dealership contract for the RB-Y1.

On the other side, technical hurdles remain, with industry voices noting that payload and battery capacity challenges mean full-scale humanoid deployment in fulfillment centers still needs more time.

Valuation

PER

5215.9×

PBR

67.3×

ROE

1.3%

EPS

₩88

BPS

₩6,823

Dividend per share

₩0

Earnings-based multiples have limited interpretive value here. Over the most recent four quarters, net profit attributable to owners has hovered near breakeven and depends substantially on non-operating items, so profit multiples are inflated by a small denominator rather than reflecting operating performance.

Relative to net assets, the shares trade at a premium far above the Korean machinery and equipment sector average, which the market attributes to weight placed on humanoid mass-production scenarios rather than current results.

Indeed, iM Securities analyst Lee Sang-soo said in a 19 May 2026 report that he maintained a Buy rating and raised the target price to KRW 915,000, assessing that the company's valuation is "entirely built on expectations for the humanoid business".

By contrast, Shinhan Securities in a May 2026 report selected Robotis, Link Solution and NBR Motion as robotics top picks along with Koh Young and SFA in robot infrastructure, showing that preferences diverge within the same industry.

On distributions, filings show no cash dividend, so funds are being directed to growth investment rather than shareholder returns, and dividend-related metrics sit below the sector average.

Across years, profitability moved from a profit in 2022 through a large operating loss in 2023 and then toward narrowing losses; whether absolute profit levels recover depends on the scale of mass-production revenue and the cost structure.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-08-23

Bull factors

Measurable growth in captive parent demand

Samsung Electronics purchased KRW 5.68bn from the company in the first half, three times the KRW 1.92bn a year earlier. Second-quarter sales to Samsung were about KRW 3.26bn, up 35.3% from KRW 2.41bn in the first quarter.

Because related-party sales are already visible in filings rather than being a forecast, they are cited as support for the growth floor. The rising share must nonetheless be read alongside the counterargument of customer concentration.

Product mix shifting toward humanoids

First-half mobile humanoid revenue of KRW 8.65bn was 40.48% of the total, making it the largest product line. The revenue axis has moved from collaborative robots toward mobile dual-arm robots, with observers noting that rising mobile humanoid sales are translating directly into top-line growth.

Quarterly revenue also rose from KRW 6.22bn in Q2 2025 to KRW 12.31bn in Q2 2026. How the mix shift feeds through to pricing and margins is the next item to verify.

Low-leverage balance sheet and in-house components

The debt-to-equity ratio fell from 23.8% in 2022 to 7.1% in 2025, with total equity of KRW 133.8bn against total liabilities of KRW 9.47bn at end-2025. In balance-sheet terms, that provides room to absorb losses while adding R&D and headcount.

On technology, the company targets a full lineup that develops and sells core parts such as dexterous hands and actuators, and industry estimates put dexterous hands at 17-31% of humanoid component costs, reflecting high technical and cost barriers.

That said, with 2025 operating cash flow at minus KRW 9.29bn, the pace at which that capital cushion is consumed also warrants monitoring.

Bear factors

Operating losses widening despite growth

Q2 2026 revenue of KRW 12.31bn was roughly double the prior-year quarter, yet the operating loss of KRW 2.03bn was similar in size to Q2 2025's KRW 2.06bn loss. The first quarter also showed revenue of KRW 9.06bn with a KRW 1.57bn operating loss.

One explanation notes that revenue rose as automation demand lifted the collaborative robot business, but operating losses persisted on higher R&D and business expansion costs (FnGuide). No confirmed company guidance is available on how long this cost front-loading continues.

Expectations already embedded and schedule risk

Critics repeatedly note that the valuation leans on future scenarios rather than current profits. One risk assessment stated that much of the future growth expectation is already reflected in the valuation, so delays in mass-production timing could amplify share-price volatility.

Industry views also hold that payload and battery capacity challenges mean full deployment in fulfillment centers requires more time. If the shift from trials to repeat orders slips, the gap between results and expectations lengthens.

Intensifying competition and reference risk

The global competitive set is expanding fast. Hyundai Motor Group unveiled a fully electric Atlas at CES 2026 with phased US plant deployment from 2028, and analysis suggests Tesla would start initial Optimus production around July-August 2026.

In defense, one assessment noted that the company co-developed a defense quadruped robot with Hyundai Rotem in August 2024 and delivered prototypes to the Army, but strengthening cooperation between Boston Dynamics and the Army has reduced the likelihood of additional supply (iM Securities). Domestically, analyst preferences are also splitting between component makers and finished-robot makers.

Risk factors

Regulatory and governance

An investigation is under way into alleged use of undisclosed information around the Samsung subsidiary transition.

The Securities and Futures Commission referred 16 people, including the company's chief executive surnamed Lee and a former chief financial officer surnamed Bang, to prosecutors for alleged capital markets law violations, formally charging two and requesting further investigation of 14.

Prosecutors searched Samsung Electronics headquarters and the company's Daejeon headquarters on 18 March 2026, and in June searched Samsung's Suwon headquarters again as part of a probe into alleged illicit gains during the 2022-2024 subsidiary transition. Uncertainty over management credibility and internal controls remains, and outcomes are not yet determined.

Earnings volatility and cash flow

Quarterly swings are wide. Q4 2025 showed revenue of KRW 13.02bn with operating profit of KRW 1.70bn, but Q1 and Q2 2026 reverted to operating losses of KRW 1.57bn and KRW 2.03bn.

Given noted seasonality in which capital expenditure budget execution concentrates in the fourth quarter, a single quarter is a poor basis for judging the trend.

Operating cash outflows widened from minus KRW 1.91bn in 2024 to minus KRW 9.29bn in 2025, so the pace of cash consumption matters if headcount and R&D expansion continue.

Customer concentration and policy dependence

A meaningful share of revenue depends on the parent group. First-half sales to Samsung Electronics were about 27% of total revenue of KRW 21.38bn, up from 18% a year earlier.

Shifts in the parent's robot priorities or organization can directly affect order volumes, and Samsung has reorganized its robot units under a body reporting directly to the CEO.

In addition, since the government targets over KRW 1trn of investment by 2030 and annual output above 1,000 units by 2029 through the K-Humanoid Alliance, changes to policy timelines are also a demand variable.

What to watch next

Mid-November 2026
Q3 2026 quarterly report. Key items are whether revenue growth sustains the first-half pace, whether the operating loss narrows despite headcount growth, and how the Samsung revenue share moves from roughly 27% in the first half.
Q4 2026
The outcome of the RB-Y1 validation at Coupang's fulfillment center and whether it converts into large-scale orders, plus progress on discussions to supply CJ logistics centers. Whether trials become repeat orders determines the durability of mobile humanoid revenue.
January 2027
The early-year exhibition and product announcement season, including CES 2027. Watch whether next-generation humanoid and core-component roadmaps such as dexterous hands are disclosed, and how they connect to the parent's robot business plans.
February-March 2027
Confirmation of full-year 2026 results and the annual business report. The core questions are actual shipments and revenue against the stated mobile humanoid capacity of about 120 units a year, and whether the annual operating result improves on 2025's KRW 2.48bn loss.
Whenever the probe concludes (undetermined)
Prosecutorial disposition and any indictment relating to the undisclosed-information allegations referred by the Securities and Futures Commission. Because management is involved, the conclusion could change assessments of governance and internal controls.

Overall view

Rainbow Robotics is shifting its product axis from collaborative robots toward mobile humanoids, and that shift already shows in the revenue line. Annual revenue rose from KRW 13.62bn in 2022 to KRW 34.12bn in 2025, and Q2 2026 revenue of KRW 12.31bn was about double the prior-year quarter.

Profitability, however, remains negative, with operating losses of KRW 1.57bn in Q1 2026 and KRW 2.03bn in Q2, leaving a wide lag between scale and earnings.

The bullish factors are captive demand, with first-half Samsung purchases tripling year on year, a conservative balance sheet with a 7.1% debt-to-equity ratio, and the in-house component strategy.

The bearish factors are persistent losses from front-loaded spending, operating cash outflows that widened to KRW 9.29bn in 2025, and a valuation structure with expectations already embedded, as reflected in the view that volatility could rise if mass-production timing slips.

On top of that sits a governance variable in the undisclosed-information allegations for which the Securities and Futures Commission referred 16 people, including the chief executive, to prosecutors.

What must be verified is how fast logistics trials at customers such as Coupang and CJ turn into repeat orders, and whether revenue growth translates into narrower operating losses. This material is for information purposes and contains no buy or sell opinion and no target price.

Sources

Korea Exchange (KRX) — Prices · Market Cap · Volume
FSS electronic disclosure system (DART) — Financial statements · Dividend filings

Show 18 more articles and sources

Report written 2026-09-05 · Data as of 2026-09-04

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.